April 17, 2026

Bundled Care Strategy May Reduce Moderate to Severe AKI

Multicenter trial finds KDIGO-recommended approach lowers moderate to severe acute kidney injury; measured 90-day outcomes were similar between groups

Conexiant

April 17, 2026

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness

Conexiant

April 16, 2026

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

Conexiant

April 13, 2026

Top 10 Evidence-Based Essentials in Cardiology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

Conexiant

April 13, 2026

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Conexiant

April 09, 2026

Factors That Impact SCPC Outcomes

A recent review led by Arash Sabati, MD, a cardiologist with Phoenix Children's, explores the superior cavopulmonary connection (SCPC), a key procedure for children with.

Phoenix Children's Medical Connection

April 09, 2026

Long COVID May Raise Cardiovascular Risk

Population-based cohort shows higher rates of cardiac arrhythmias and coronary artery disease following nonhospitalized infections, with sex-specific differences.

Conexiant

April 08, 2026

Advancing heart health remains as a top priority for UCI Health

The annual Advances and Essentials in Cardiovascular Disease Conference took place at UCI Beall Applied Innovation.

UCI Health

April 07, 2026

FDA Approves First Generic Versions of FARXIGA

Agency approves multiple dapagliflozin generics to reduce heart failure hospitalization risk and improve glycemic control in adults with type 2 diabetes

Conexiant

April 07, 2026

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes

Conexiant